Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
PHASE4
INTERVENTIONAL
2021-07-31
2021-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Combined Alcohol and Cannabis Effects on Skills of Young Drivers
NCT03106363
Effects of Cannabis/Alcohol on Driving Performance and Field Sobriety Tests
NCT05273658
Alcohol Effects on Driving-related Skills of Young Drivers
NCT02710578
Marijuana Effects on Simulated Driving Performance
NCT03699540
Effects of Inhaled Cannabis on Driving Performance
NCT01620177
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
FACTORIAL
BASIC_SCIENCE
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
THC 0 + BAC 0
Participants will receive 0mg of THC in combination with blood alcohol concentrations of .000%.
THC 0
THC dose = 0mg
BAC 0
Blood alcohol concentration = .000%
THC 5 + BAC 0
Participants will receive 5mg of THC in combination with blood alcohol concentrations of .000%.
THC 5
THC dose = 5mg
BAC 0
Blood alcohol concentration = .000%
THC 10 + BAC 0
Participants will receive 10mg of THC in combination with blood alcohol concentrations of .000%.
THC 10
THC dose = 10mg
BAC 0
Blood alcohol concentration = .000%
THC 5 + BAC .025
Participants will receive 5mg of THC in combination with blood alcohol concentrations of .025%.
THC 5
THC dose = 5mg
BAC .025
Blood alcohol concentration = .025%
THC 10 + BAC .025
Participants will receive 125 µg/kg of THC in combination with blood alcohol concentrations of .025%.
THC 5
THC dose = 5mg
BAC .025
Blood alcohol concentration = .025%
THC 0 + BAC .049
Participants will receive 0 µg/kg of THC in combination with blood alcohol concentrations of .049%.
THC 0
THC dose = 0mg
THC 10
THC dose = 10mg
BAC .025
Blood alcohol concentration = .025%
BAC .049
Blood alcohol concentration = .049%
THC 5 + BAC .049
Participants will receive 5mg of THC in combination with blood alcohol concentrations of .049%.
THC 5
THC dose = 5mg
BAC .049
Blood alcohol concentration = .049%
THC 10 + BAC .049
Participants will receive 10mg of THC in combination with blood alcohol concentrations of .049%.
THC 5
THC dose = 5mg
BAC .049
Blood alcohol concentration = .049%
THC 0 + BAC .025
Participants will receive 0 µg/kg of THC in combination with blood alcohol concentrations of .025%.
THC 0
THC dose = 0mg
THC 10
THC dose = 10mg
BAC .025
Blood alcohol concentration = .025%
BAC .049
Blood alcohol concentration = .049%
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
THC 0
THC dose = 0mg
THC 5
THC dose = 5mg
THC 10
THC dose = 10mg
BAC 0
Blood alcohol concentration = .000%
BAC .025
Blood alcohol concentration = .025%
BAC .049
Blood alcohol concentration = .049%
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* valid G2 or G Ontario driver's license
* live on-campus or within 15 minutes drive of campus
* speak fluent English
Exclusion Criteria
* current use of psychoactive medication
* current drug or alcohol abuse problem
* positive drug screen
* BAC level \> .000%
19 Years
25 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Lakehead University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Michel Bédard, PhD
Role: PRINCIPAL_INVESTIGATOR
Lakehead University
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2018502
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.